Transformation into a Growth-Focused Business
Tate & Lyle completed its structural transformation into a growth-focused specialty business following the combination with CP Kelco.
Financial Performance
Despite a challenging environment, Tate & Lyle delivered a robust financial performance with EBITDA growth of 4%, and an EBITDA margin of 21%.
Sucralose Segment Success
Sucralose revenue was up 16%, while EBITDA grew 18%, with an EBITDA margin increase to 31.1%.
Productivity and Cost Management
Delivered $50 million in productivity savings, exceeding targets, with $33 million from operational efficiencies and $17 million from cost management.
Innovation and New Products
Revenue from new products grew 9% on a like-for-like basis, with $80 million invested in innovation and solution selling.
CP Kelco Integration and Synergies
CP Kelco integration is progressing well, with expected cost synergies of $50 million by 2027 and revenue synergies targeted at 10% of CP Kelco's revenue.